We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
How to use routinely collected data to evaluate your digital health product.
How to use a before-and-after study to evaluate your digital health product.
How to use a combination of quantitative and qualitative data to evaluate your digital health product.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Data on the real-world efficacy of the COVID-19 vaccines.
How to use an interrupted time series to evaluate your digital health product.
How to use a randomised controlled trial to evaluate your digital health product.
How to use a crossover randomised controlled trial to evaluate your digital health product.
How to write up and share your findings
How to use a patient-reported outcomes and experiences study to evaluate your digital health product.
How to use a quasi-experimental study to evaluate your digital health product.
How to use an ethnographic study to evaluate your digital health product.
How to use a feasibility study when planning the evaluation of your digital health product.
How to use a factorial randomised controlled trial to evaluate your digital health product.
Providing vital research into COVID-19 immunity and vaccine effectiveness nationally.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
How to use a micro-randomised trial to evaluate your digital health product.
How to use an N-of-1 study to evaluate your digital health product.
What you need to know about being part of the data use and productivity study.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.